A recent international study highlights the significant economic burden of depression in Morocco, beyond its health impact. The research, conducted by the Lancet Commission on global mental health, estimates that depression and anxiety disorders cost the global economy $1 trillion annually in lost productivity. For Morocco, this translates into billions of dirhams lost each year due to reduced workforce participation and decreased productivity.
The study emphasizes that mental health conditions are a leading cause of disability worldwide, affecting individuals' ability to work and contribute to economic growth. In Morocco, the prevalence of depression is estimated at around 5.2% of the population, according to the World Health Organization (WHO). This means over 1.8 million Moroccans are affected, many of whom do not receive adequate treatment.
Experts argue that investing in mental health care is not only a moral imperative but also an economic one. The Lancet Commission recommends scaling up evidence-based interventions, such as cognitive behavioral therapy and antidepressant medication, which have been shown to be cost-effective. In Morocco, the government has taken steps to integrate mental health into primary care, but funding remains limited, with less than 1% of the health budget allocated to mental health.
The economic case for action is clear: for every $1 invested in scaling up treatment for depression and anxiety, there is a $4 return in improved health and productivity, according to the WHO's Mental Health Gap Action Programme. As Morocco continues to develop, addressing mental health is crucial for sustainable economic growth and the well-being of its citizens.
